MDM4 and ovarian carcinoma: Although we observed no significant association between MDM4 SNP34091 status and ovarian cancer risk, applying the dominant model (SNP34091CC + AC vs. AA) we observed a non-significant association with increased risk for ovarian cancer (OR = 1.12; 95 % CI = 0.98–1.29; Table 1).